EXPERIENCE IN OUR CENTER WITH THE USE OF RITUXIMAB - VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Pimentel, Villar Ma [1 ]
De Leon, Marcano E. [1 ]
Jimenez, Moreno M. [1 ]
Lopez, Marquez T. J. [1 ]
Almagro, Torres F. [1 ]
Lopez, Lopez J. A. [1 ]
机构：
[1] Hosp Univ Jaen, Jaen, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-049
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [1] Venetoclax-Rituximab in Chronic Lymphocytic Leukemia
    Copur, Mehmet S.
    Gauchan, Dron
    Crockett, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2142 - +
  • [2] Venetoclax-Rituximab in Chronic Lymphocytic Leukemia REPLY
    Seymour, John F.
    Mobasher, Mehrdad
    Kater, Arnon P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2143 - +
  • [3] Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience
    Ozmen, Deniz
    Keskin, Dilek
    Yurttas, Nurgul Ozgur
    Sadri, Sevil
    Salihoglu, Ayse
    Eskazan, Ahmet Emre
    Ar, M. Cem
    Ongoren, Seniz
    Baslar, Zafer
    Soysal, Teoman
    BLOOD, 2017, 130
  • [4] Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Seymour, J. F.
    Kipps, T. J.
    Eichhorst, B.
    Hillmen, P.
    D'Rozario, J.
    Assouline, S.
    Owen, C.
    Gerecitano, J.
    Robak, T.
    De la Serna, J.
    Jaeger, U.
    Cartron, G.
    Montillo, M.
    Humerickhouse, R.
    Punnoose, E. A.
    Li, Y.
    Boyer, M.
    Humphrey, K.
    Mobasher, M.
    Kater, A. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12): : 1107 - 1120
  • [5] Venetoclax Approved for Use in Chronic Lymphocytic Leukemia
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 339 - 339
  • [6] Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab
    Robak, Ewa
    Jesionek-Kupnicka, Dorota
    Stelmach, Piotr
    Kupnicki, Piotr
    Szataniak, Magdalena
    Robak, Tadeusz
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1387 - 1392
  • [7] Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab
    Ewa Robak
    Dorota Jesionek-Kupnicka
    Piotr Stelmach
    Piotr Kupnicki
    Magdalena Szataniak
    Tadeusz Robak
    Annals of Hematology, 2022, 101 : 1387 - 1392
  • [8] The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia
    Vitale, Candida
    Ferrajoli, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (08) : 885 - 894
  • [9] Use of Venetoclax Combination Regimens in Chronic Lymphocytic Leukemia
    Tam, Constantine S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 504 - 506
  • [10] The spectrum of use of rituximab in chronic lymphocytic leukemia
    Tedeschi, Alessandra
    Vismara, Eleonora
    Ricci, Francesca
    Morra, Enrica
    Montillo, Marco
    ONCOTARGETS AND THERAPY, 2010, 3 : 227 - 246
12345